v3.25.1
Other financial liabilities - Additional Information (Detail)
Oct. 28, 2024
May 17, 2024
$ / shares
Nov. 30, 2023
AUD ($)
Dec. 31, 2024
AUD ($)
Jul. 11, 2024
shares
$ / shares
Nov. 30, 2023
$ / shares
Nov. 30, 2023
AUD ($)
shares
Disclosure of Changes in Other Financial Liabilities Current [Line Items]              
Exercise price | $ / shares           $ 0.583  
Fair Value Warrants Issued | $       $ 5,445,887      
Weighted average exercise price of other equity instruments exercisable in share-based payment arrangement | $ / shares           $ 0.583  
Rate of consideration for purchasing warrants       5.00%      
Amount for determining exercise price of warrants | $       $ 6,000,000      
Description of transactions after reporting period that significantly change number of ordinary shares outstanding the Consolidated Entity had changed the ratio of its ADSs to Ordinary Shares from one (1) ADS representing ten (10) Ordinary Shares to one (1) ADS representing one hundred (100) Ordinary Shares. There will be no change to our underlying Ordinary Shares, and no Ordinary Shares will be issued or cancelled in connection with the ADS ratio change prior to 28 October 2024.            
Securities Purchase Agreement [Member]              
Disclosure of Changes in Other Financial Liabilities Current [Line Items]              
Fair Value Warrants Issued | $             $ 132,763
Transaction cost incurred for issue of warrants | $     $ 382,463        
Prefunded Warrants [Member]              
Disclosure of Changes in Other Financial Liabilities Current [Line Items]              
Number of other equity instruments exercisable | shares             1,824,445
Number of other equity instruments exercisable in share-based payment arrangement | shares             1,824,445
Ordinary Warrants [Member]              
Disclosure of Changes in Other Financial Liabilities Current [Line Items]              
Number of other equity instruments exercisable | shares             4,444,445
Number of other equity instruments exercisable in share-based payment arrangement | shares             4,444,445
Ordinary Warrants [Member] | Securities Purchase Agreement [Member]              
Disclosure of Changes in Other Financial Liabilities Current [Line Items]              
Financial liabilities, at fair value | $             $ 3,020,316
American Depositary Shares [Member]              
Disclosure of Changes in Other Financial Liabilities Current [Line Items]              
Number of shares issued | shares             2,620,000
Number of other equity instruments exercisable   1,100,000          
Exercise price | $ / shares   $ 0.27          
Number of other equity instruments exercisable in share-based payment arrangement   1,100,000          
Weighted average exercise price of other equity instruments exercisable in share-based payment arrangement | $ / shares   $ 0.27          
Decrease exercise price of warrant | $ / shares   $ 0.27          
New American Depositary Shares [Member]              
Disclosure of Changes in Other Financial Liabilities Current [Line Items]              
Number of other equity instruments exercisable | shares         1,100,000    
Exercise price | $ / shares         $ 0.27    
Number of other equity instruments exercisable in share-based payment arrangement | shares         1,100,000    
Weighted average exercise price of other equity instruments exercisable in share-based payment arrangement | $ / shares         $ 0.27    
Warrants Alumini Capital American Depositary Shares [Member]              
Disclosure of Changes in Other Financial Liabilities Current [Line Items]              
Number of other equity instruments exercisable | shares         2,578,648    
Exercise price | $ / shares         $ 0.1939    
Number of other equity instruments exercisable in share-based payment arrangement | shares         2,578,648    
Weighted average exercise price of other equity instruments exercisable in share-based payment arrangement | $ / shares         $ 0.1939